Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

CVS HEALTH CORPORATION : Ex-dividend day for

10/21/2020 EST

A dividend is removed today from CVS Health Corporation's share.



© Factset 2020
All news about CVS HEALTH CORPORATION
11/24CVS HEALTH : Leading global vision nonprofit OneSight teams with Aetna to provid..
PU
11/23CVS HEALTH : Names Neela Montgomery President of CVS Pharmacy
DJ
11/23CVS HEALTH : Names Neela Montgomery President of CVS Pharmacy
PR
11/19Walgreens offers 30-minute pickup for online shoppers
RE
11/17Wall Street closes lower as shutdown worries loom
RE
11/17Amazon launches online pharmacy in new contest with drug retail
RE
11/17Stock Futures Edge Down After Dow Hits Record
DJ
11/17S&P, Dow futures retreat as coronavirus cases spike
RE
11/17Stock Futures Edge Down After Dow Hits Record
DJ
11/17Food-Service Distributor Sysco Names New CFO
DJ
More news
Financials (USD)
Sales 2020 268 B - -
Net income 2020 7 500 M - -
Net Debt 2020 55 969 M - -
P/E ratio 2020 12,0x
Yield 2020 2,96%
Capitalization 88 522 M 88 522 M -
EV / Sales 2020 0,54x
EV / Sales 2021 0,48x
Nbr of Employees 290 000
Free-Float 75,4%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 82,46 $
Last Close Price 67,63 $
Spread / Highest target 50,8%
Spread / Average Target 21,9%
Spread / Lowest Target -2,41%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President